Here's a detail that surprises most people: getting your genome sequenced is the easy, fast part. A modern lab can read all 3+ billion base pairs of your DNA in a matter of hours. What takes real time — sometimes years, in rare disease cases — is figuring out what any one of the thousands of variants found in that data actually means for your health. That interpretation bottleneck, not sequencing speed, has been genetics' real rate-limiting step for over a decade. AI is now attacking it directly.
Why interpretation is so much harder than sequencing
Every person's genome contains millions of variants compared to the reference genome — the overwhelming majority harmless. Sorting the handful of medically relevant needles from that haystack requires cross-referencing population frequency databases, functional studies, family segregation data, and computational predictions, then applying formal classification criteria to sort each variant into one of five categories: pathogenic, likely pathogenic, uncertain significance, likely benign, or benign. That process is genuinely labor-intensive for human geneticists — and it's exactly the kind of large-scale pattern-recognition problem AI is well-suited to accelerate.
AlphaMissense
Classifies the likely effect of missense mutations across the genome — giving researchers and clinicians a starting-point prediction instead of building one from scratch for every new variant.
Genome-wide interpretation tools
Systems like Fabric GEM integrate a patient's variants with their clinical symptoms to rank candidate diagnoses automatically, rather than requiring manual review of every flagged variant.
Where the time savings actually matter most
Nowhere is speed more consequential than in newborn intensive care. Research has repeatedly shown that reaching a genetic diagnosis within the first 24-48 hours of a critically ill newborn's life can meaningfully improve outcomes — because it changes real-time treatment decisions. AI-assisted genome interpretation tools built specifically for this setting have demonstrated the ability to rank the true causative variant near the top of a ranked list, compressing a process that traditionally took specialist geneticists days or weeks of manual review.
A 2026 tool called EvORanker, developed at Hebrew University, takes a different but complementary approach — comparing evolutionary conservation patterns across more than 1,000 species to surface gene-disease relationships that hadn't been documented in existing medical literature at all. That's a meaningfully different capability than classifying known variants faster: it's AI helping discover entirely new disease-gene connections.
What this means for your own results
If you've had whole genome sequencing done, the interpretation layer sitting on top of your raw data is not static. As AI-assisted interpretation tools mature and get validated, previously unresolved variants of uncertain significance can be reclassified — sometimes years after the original test — without you needing to resequence anything. This is part of why keeping your raw genome data, not just a static PDF report, has lasting value.
Your raw data keeps getting more useful over time
A full WGS file from Dante Labs is yours to reanalyze as interpretation tools improve — today's uncertain finding could be tomorrow's answered question.
Get Your Whole Genome Sequenced → Use code GENOME for 10% off at Dante LabsThe story of genomics over the next decade may have less to do with sequencing getting cheaper — it's already remarkably cheap — and more to do with AI closing the gap between "we read your DNA" and "we understand what it's telling you."